Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMX101 4% for moderate-to-severe acne vulgaris (China Phase 3)
CTR20211291Phase 3Completed
- Sponsor
- Foamix Pharmaceuticals Ltd.
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minocycline in acne vulgaris, sponsored by Foamix Pharmaceuticals Ltd.. Started Jun 2021; status: completed.
02
Drugs
minocycline
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on CTR20211291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211291.